Inhibrx, Inc. Common Stock
INBX
INBX was delisted on the 29th of May, 2024.
126 hedge funds and large institutions have $1.34B invested in Inhibrx, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 38 increasing their positions, 38 reducing their positions, and 27 closing their positions.
0% more funds holding
Funds holding: 126 → 126 (0)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
0% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 27
0% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 38
13% less capital invested
Capital invested by funds: $1.54B → $1.34B (-$204M)
44% less call options, than puts
Call options by funds: $2.44M | Put options by funds: $4.33M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$38.5M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$34.6M |
| 3 |
Walleye Capital
New York
|
+$29.2M |
| 4 |
State Street
Boston,
Massachusetts
|
+$28.5M |
| 5 |
TCM
Tang Capital Management
San Diego,
California
|
+$25.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WP
Woodline Partners
San Francisco,
California
|
-$88.1M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$76.4M |
| 3 |
VPC
Vestal Point Capital
New York
|
-$58.1M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$53.5M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$41.1M |
INBX Hedge Fund Activity: Q1 2024 in Review
126 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Inhibrx, Inc. Common Stock (INBX) for Q1 2024, worth a combined $1.34B — down 13% from $1.54B a quarter earlier.
Fund positioning in INBX was balanced in Q1 2024: 27 funds opened new positions, 27 closed out, 38 added to existing stakes and 38 trimmed.
The largest buyer was Alpine Associates Management, opening a new position worth an estimated $38.5M. The largest seller was Woodline Partners, exiting entirely with an estimated $88.1M sold.
- 126 institutional investors held Inhibrx, Inc. Common Stock (INBX) as of Q1 2024, unchanged from Q4 2023.
- Funds reported $1.34B of Inhibrx, Inc. Common Stock stock for Q1 2024, down 13% quarter-over-quarter.
- 27 funds opened new Inhibrx, Inc. Common Stock positions in Q1 2024 and 27 closed out, a net change of 0 holders.
- The largest Inhibrx, Inc. Common Stock buyer in Q1 2024 was Alpine Associates Management, an estimated $38.5M added.
- The largest Inhibrx, Inc. Common Stock seller in Q1 2024 was Woodline Partners, an estimated $88.1M sold.
Based on aggregated 13F filings for Q1 2024.